Andrea Ellis
Insider Reports History
- Location
- Palo Alto, CA
- Signature
- /s/ Will Solis, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Andrea Ellis:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. | Director | Common Stock | 18,589 | $1,205,833 | $64.87 | 04 Mar 2026 | Direct |
| BridgeBio Pharma, Inc. | Director | Stock Option (right to buy) | 0 | 04 Mar 2026 | Direct |
Insider Reports Filed by Andrea Ellis
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | 04 Mar 2026 | 3 | -$4,211,302 | 4 | Director | 06 Mar 2026, 16:57 |
| BBIO | BridgeBio Pharma, Inc. | 05 Aug 2025 | 3 | -$553,636 | 4 | Director | 07 Aug 2025, 16:50 |
| BBIO | BridgeBio Pharma, Inc. | 20 Jun 2025 | 2 | $0 | 4 | Director | 24 Jun 2025, 19:12 |
| BBIO | BridgeBio Pharma, Inc. | 14 Apr 2025 | 3 | -$265,500 | 4 | Director | 16 Apr 2025, 17:39 |
| BBIO | BridgeBio Pharma, Inc. | 01 Apr 2025 | 3 | -$768,000 | 4 | Director | 03 Apr 2025, 17:11 |
| BBIO | BridgeBio Pharma, Inc. | 21 Jun 2024 | 1 | $0 | 4 | Director | 25 Jun 2024, 17:39 |
| BBIO | BridgeBio Pharma, Inc. | 21 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 16:18 |
| BBIO | BridgeBio Pharma, Inc. | 22 Jun 2022 | 1 | $0 | 4 | Director | 24 Jun 2022, 16:28 |
| BBIO | BridgeBio Pharma, Inc. | 15 Mar 2022 | 1 | +$100,680 | 4 | Director | 17 Mar 2022, 16:05 |
| BBIO | BridgeBio Pharma, Inc. | 17 Aug 2021 | 1 | $0 | 4 | Director | 26 Aug 2021, 17:14 |
| BBIO | BridgeBio Pharma, Inc. | 17 Aug 2021 | 0 | $0 | 3 | Director | 26 Aug 2021, 16:35 |